Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
about
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical UseSEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).Micropapillary Bladder Cancer: Insights from the National Cancer DatabaseClinical risk stratification in patients with surgically resectable micropapillary bladder cancer.Contemporary update on neoadjuvant therapy for bladder cancer.The Role of Pontin and Reptin in Cellular Physiology and Cancer Etiology.The luminal-basal paradigm in the urothelial cancer: hope for individualized approach.FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.Characteristics and clinical significance of histological variants of bladder cancer.miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma.Intratumoral Heterogeneity of ERBB2 Amplification and HER2 Expression in Micropapillary Urothelial Carcinoma.LncRNA PCAT1 and its genetic variant rs1902432 are associated with prostate cancer risk.Intrinsic subtypes and bladder cancer metastasis.Understanding the biology of urothelial cancer metastasis.Exploration of genetics commonness between bladder cancer and breast cancer based on a silcio analysis on disease subtypes.
P2860
Q33784670-272C4389-3C9E-433A-A8CE-B1E3AC80AF5BQ37363521-828AD45D-401F-4FC5-B8C7-B70B3F361EB7Q37475193-571B2FE5-5EB1-4891-81E4-8E227C86513FQ37530374-B24457A8-3B11-4583-A47F-C4BB553552ADQ38983687-A121136A-A5C3-4812-80F5-FE3460B7AF04Q39177293-64E52480-5CF3-48B5-A1AE-18E6A920B4FAQ41539424-9A822054-96F3-46B6-9496-053C0A56FFA2Q42343424-66DCF128-A3AA-4291-9D44-1BA5D248CA92Q42512532-BF996A1F-753D-4CB3-A0D1-DBB416388B45Q47998264-4E76EBEC-8844-47B1-875D-94F374AEB1F9Q51420219-A783A6AD-6735-4342-BF9B-363EABCD50C2Q52618828-60DBC0AE-A459-4F63-9835-4CF4A02C90C0Q54997143-5D818F03-7380-45C1-A460-2154C31BA926Q55078504-AE2FC8B8-B0B6-4467-A528-C6C19D2FC0B1Q55126311-496A9BF8-927A-488D-8587-C8958EDF4E8CQ55423400-1B22C4F9-6A5B-425B-86BD-244E486DF75C
P2860
Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Gene Expression Profile of the ...... ary Variant of Bladder Cancer.
@en
type
label
Gene Expression Profile of the ...... ary Variant of Bladder Cancer.
@en
prefLabel
Gene Expression Profile of the ...... ary Variant of Bladder Cancer.
@en
P2093
P2860
P1433
P1476
Gene Expression Profile of the ...... lary Variant of Bladder Cancer
@en
P2093
Arlene Siefker-Radtke
Ashish Madhav Kamat
Bogdan Czerniak
Charles Chuanhai Guo
Colin Dinney
David McConkey
John N Weinstein
Jolanta Bondaruk
Keith A Baggerly
P2860
P304
P356
10.1016/J.EURURO.2016.02.056
P407
P577
2016-03-15T00:00:00Z